Cargando…
To manage long COVID by selective SARS-CoV-2 infection biosensing
Autores principales: | Kaushik, Ajeet, Mostafavi, Ebrahim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365706/ https://www.ncbi.nlm.nih.gov/pubmed/35971552 http://dx.doi.org/10.1016/j.xinn.2022.100303 |
Ejemplares similares
-
SARS-CoV-2 getting into the brain; neurological phenotype of COVID-19, and management by nano-biotechnology
por: Kujawska, Małgorzata, et al.
Publicado: (2022) -
Selenium-based nanomaterials for biosensing applications
por: Mostafavi, Ebrahim, et al.
Publicado: (2022) -
SARS-CoV-2-on-Chip for Long COVID Management
por: Cherusseri, Jayesh, et al.
Publicado: (2022) -
SARS‐CoV‐2 Omicron variant: A next phase of the COVID‐19 pandemic and a call to arms for system sciences and precision medicine
por: Mostafavi, Ebrahim, et al.
Publicado: (2022) -
Updates in Management of SARS-CoV-2 Infection
por: Flisiak, Robert, et al.
Publicado: (2022)